← Scoopfeeds — Intelligent news, curated.
AstraZeneca PLC (AZN) Stock Falls as FDA Panel Votes Against New Cancer Drug
business

AstraZeneca PLC (AZN) Stock Falls as FDA Panel Votes Against New Cancer Drug

Yahoo Finance · May 12, 2026, 12:03 AM · Also reported by 1 other source

AstraZeneca PLC (AZN) Stock Falls as FDA Panel Votes Against New Cancer Drug

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Gilat Satellite Networks stock falls over 6% on revenue miss despite earnings beat

More in business

Investing.com
German court rules Milka chocolate bar weight cut misleading
Investing.com
Trump’s designs on Greenland prod investment, tourism likely to pay off faster than mines
Investing.com
Argus cuts Constellation Energy stock price target on valuation
Investing.com
Argus raises New York Times stock price target to $88 on digital growth
Investing.com
Argus raises First Solar stock price target to $275 on trade position
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop